You are here

Pfizer

Pfizer bows first Ibrance TV spot as Novartis revs up with rival breast cancer med Kisqali

Fierce Pharma

Wed, 05/24/17 - 10:37 am

Astellas, Pfizer scrap a PhIII breast cancer study using Xtandi; New $30M fund will back Israeli biotech startups

Endpoints

Sat, 05/20/17 - 12:50 pm

clinical trials

Iterum bags $65M for phase 3 trial of ex-Pfizer antibiotic

Fierce Biotech

Fri, 05/19/17 - 10:19 am

clinical trials

ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say

Fierce Pharma

Thu, 05/18/17 - 08:00 pm

The top 15 generic drugmakers by 2016 revenue

Fierce Pharma

Wed, 05/17/17 - 09:39 am

Teva Pharmaceutical

Here's Why the Best Is Yet to Come for Pfizer Inc.

Motley Fool

Mon, 05/15/17 - 08:59 am

Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal

Endpoints

Thu, 05/11/17 - 11:21 am

Sangamo BioSciences

Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town

Fierce Pharma

Wed, 05/10/17 - 09:31 am

Pfizer collaborates to improve access to injectable contraceptive

Drug Delivery Business News

Tue, 05/9/17 - 10:25 am

injectable contraceptives

FDA’s Ruling on Generic ZITHROMAX 180-Day Exclusivity: A Little Something for Everyone!

FDA Law Blog

Mon, 05/8/17 - 11:32 am

Pfizer, awaiting a final NICE verdict, doles out free Ibrance in the U.K.

Fierce Pharma

Sun, 05/7/17 - 10:23 am

Merck vs. Pfizer: Which Stock Looks Better Post-Earnings?

Yahoo/Zacks.com

Sun, 05/7/17 - 10:16 am

Pfizer making progress on Hospira manufacturing issues, execs say

BioPharma Dive

Fri, 05/5/17 - 10:15 am

drug manufacturing

With Pfizer’s Xtandi sales slowing, analysts question $14B Medivation price

Fierce Pharma

Wed, 05/3/17 - 02:15 pm

So what’s holding back Pfizer and Gilead from the really big M&A deals we’ve all been waiting for?

Endpoints

Wed, 05/3/17 - 10:54 am

Gilead Sciences

Is Pfizer really weighing a BMS buy? Clues from Q1's earnings call say it just may be

Fierce Pharma

Wed, 05/3/17 - 10:09 am

Bristol-Myers Squibb

3 Reasons Pfizer, Inc. Investors Shouldn't Be Concerned About the Q1 Revenue Dip

Motley Fool

Wed, 05/3/17 - 10:08 am

Pfizer beats 1Q profit forecasts, but sales dip misses views

Yahoo/AP

Tue, 05/2/17 - 11:33 am

3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan

Motley Fool

Mon, 05/1/17 - 11:48 am

Gilead Sciences

Earnings Preview: What To Expect From Pfizer On Tuesday

Forbes

Mon, 05/1/17 - 11:37 am

Pages